Month: April 2015

Blue Horseshoe Stocks: PMCB Update & More

PharmaCyte Biotech, Inc. PMCB

When we released a special report on PMCB back on Tuesday of last week, we commented on the promising nature of trials the company currently has underway relating to various treatments based on its Cell-in-a-Box® technology.

At the end of last week, PharmaCyte announced some promising research specifically pertaining to its diabetes treatment, with the claim that it can actually reverse Type-1 Diabetes in mice.The full paper can be found at http://www.nature.com/articles/mtm201511. Human trials are the next step to take, and needless to say, should the treatment prove effective using PMCB’s encapsulation technology (that we described in our initial report,) acquisition by a large pharmaceutical company could become a very real possibility.

That also seems to be the thinking on the Street, as PMCB has made some impressive strides on the chart over the past several sessions. From the low of .12 that we observed in this play on 04/08, it has made its way up as high as .22; a respectable 83% overall increase. That impressive high came during yesterday’s session in conjunction with a breach of the current 200DMA of .19.

PMCB will be one that we want to keep on continuous watch due to its potentially industry-disruptive diabetes treatment.

Pazoo, Inc. PZOO

PZOO has been a flipper’s dream since we re-initiated coverage on it just a couple of weeks ago. Yesterday’s low registered as .008 before the stock bounced back to .0097, a 21% intraday swing.

It was the same story on Wednesday; we saw PZOO dip to a low of .0074 before returning as high as .0103 (+39%) We’ve continually stated that we’d like to see the stock trading at or above the .008 range which, for the most part, it has continued to do.

CEO David Cunic appeared in an audio interview yesterday, and this morning we’re seeing another PR directing our attention to an 8-K filing which outlines a recent agreement, among other things, so our readers might want to check out those links.

In the meantime, we’ll be on the lookout for upcoming intraday gain opportunities from PZOO, such as those that it has delivered numerous time over the past several sessions.

Identiv, Inc. INVE

We also want to make a quick mention of INVE, which made a solid 14% move yesterday as it traded in a range from 11.12-12.67. It came on over ten times the 3-month average volume, so we’ll be observing this one as the week draws to a close, and possibly into next week.

Extended Watchlist:
RXII, ONCY, ZBB, UNXL

Blue Horseshoe Stocks: OSLH, PBR Updates & More

OSL Holdings, Inc. OSLH

OSLH is going to go down in the books as one of our hottest stock calls of the year following its epic run over the past couple of weeks.

We alerted this play on April 1st after it popped up on a scan the previous day. On April 2nd, we witnessed a low of .0021 in OSLH, and what happened next has been nothing short of astounding.

OSLH hit a high of .0274 during trading yesterday. It has accounted for an incredible 1294% rip in just ten sessions’ time. A big cheer goes out to anyone else who was able to get a piece of that rather large pie!

Petroleo Brasiliero S.A. (Petrobras) PBR

Like clockwork, PBR continued its impressive recovery from recent lows. The stock was trading at a low of 5.60 following our turning attention back to PBR back on 03/26. As of yesterday’s high of 8.90, the stock itself has rebounded a remarkable 59%

We’ve been consistently rolling up our strike prices as PBR has advanced on the charts. Our readers will recall that we mentioned our interest in Weekly In-the-money Calls, and anyone who entertained the $8 and $8.50 Weekly Calls as PBR pushed close to $9 this midweek, were in for some serious gain opportunities.

Yesterday alone, $8 Calls ran from .35-.87 (+148%), while the $8.50’s traded in a range from .13-.44 (+238%).

Molycorp, Inc. MCP

We’ve been tracking MCP of late, before yesterday, tagging the stock in our morning report from April 9th. Subsequent to that, we witnessed a low of .48 (04/13-04/14).

Yesterday brought a strong move from .68 to .96, which represents an intraday gain of 41%, and an overall increase of 100% over lows that were established just a couple of sessions back.

The stock is closing in on a dollar here in premarket trading, so we’ll need to keep an eye peeled, because MCP may yet have some ground to cover.

Voltari Corp. VLTC

VLTC has been another majorly successful recent call; we made this one along with OSLH in our Extended Watchlist back on April 1st. Subsequent to that, we observed a low of 2.18 and at yesterday’s high of 9.89 the stock had risen by 354%

Extended Watchlist:
MNOV, INVE, CLRX

Blue Horseshoe Stocks: Late Breaking News – PZOO

Pazoo, Inc. PZOO

Yesterday, PZOO continued its trend of producing healthy daily swings, While PZOO did dip briefly below the 50DMA early on, it gave us a chance at a respectable intraday gain, as it has already done several times in the past couple of weeks. The daily range carried the stock from a low of .0074 back up to the penny mark; a 35% move that came on greater than average volume.

We were recently updated on the status of Pazoo partner, MA & Associates, whose cannabis testing facilities still await the first shipments of product for testing. The State of Nevada has delayed the release of regulatory guidelines for growers pertaining to standardized levels of pesticides, pushing the expected date of first delivery to sometime in June. It does give newly appointed marketing and sales executive Michael Tulimero added time to position the company to secure an even larger presence with growers, who are undoubtedly anticipating the regulatory green light from the State as eagerly as anyone. >> READ PR

We want to take note of the significant PR that just hit the wires at 9:45am:

WHIPPANY, N.J., April 15, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC:PZOO), is pleased to announce that as of yesterday, the company has completely repaid the total of its obligations on its Convertible Promissory Notes to LG Capital Funding LLC and Macallan Partners LLC. In addition, Pazoo has given notice of its intention to fully pay off the Convertible Promissory Notes held by Union Capital LLC by the end of next week and Eastmore Capital LLC within the next two weeks. The total of the obligations, repaid and planned for the next two weeks, is approximately $400,000.

Pazoo as a company felt it extremely important to eliminate any conversions of these notes into free trading shares of the company’s common stock. With the tremendous strides recently attained through our 100% subsidiary, Harris Lee, LLC and 40% owned MA & Associates, LLC, Pazoo is currently working towards more traditional financing vehicles. This will also tremendously benefit the company as it will free up tens of millions of reserve shares for the company’s use. >> VIEW FULL PR

Extended Watchlist:
ANGI, CLSN, FOMX, MCP, OSLH, PBR